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Abstract
Background:  Selenium (Se) is a non-metal element, occurring in varying degrees in the
environment and it has been found to be a component of several enzymes. Different selenium
compounds have been associated with carcinogenicity, toxicity, modification of metal toxicity and
prevention of cancer. Organoselenium compounds had substantially greater bioavailability and less
toxicity than that of inorganic selenium. From a chemical point of view, Se resembles sulfur (S) in
many of its properties, thus, Se and S may be considered to be isosteric. The ability of a synthetic
organoselenium compound; cyclopenta-dienyldicarbonyl ironselenoterephthalic acid (CSe) and its
sulfur analogue (CS) in the range of 10-8 to 10-5 M, to induce sister-chormatid exchanges (SCE) and
alter cell division expressed as mitotic index (MI) as well as cell survival has been investigated.
Methods: Rat bone marrow cells were cultured in the presence of CSe and CS in the range of 10-
8 to 10-5 M with a total exposure time of 4, 16 or 28 h at 37°C. Fluorescence-plus-Giemsa (FPG)
technique was used to visualize chromosomes for SCE analysis and MI determination. Trypan blue
exclusion technique was used to determine cell viability.
Results:  At the three exposure times, cell survival progressively decreased with increasing
concentration, but the effect of either chemical was not significant (ANOVA; P < 0.05) as compared
to the negative control. Significant reductions in MI were calculated at the highest concentration
(10-5 M) when either chemical was applied for 16 or 28 h. Furthermore, the mean SCE increased
with longer exposure times and, in general, CSe had slightly greater effect on cell survival and
caused higher frequencies of SCE than CS. The exception was the 10-8 M treatment. However, both
CSe and CS failed to induce 2-fold SCE as that of the negative control and therefore they are not
considered as mutagens.
Conclusion: Both CSe and CS in the range of 10-8 to 10-5 M could not double the SCE rate of the
negative control and therefore not considered as mutagens at these experimental conditions.
Background
Selenium (Se) is a non-metal element [1], occurring in
varying degrees in soil, water, plants and grains. Se has
been found to be a component of glutathione peroxidase
(GSH-Px) as selenocysteine (SeCys). In addition of many
other enzymes, SeCys is also found in the active site of two
mammalian enzymes, phospholipids hydroxide GSH-Px,
and 5-deiodinase [2].
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From a chemical point of view, Se resembles sulfur (S) in
many of its properties [3]. Se and S may be considered to
be isosteric, as originally defined by Langmuir,1919 [4].
The biological and pharmaceutical activities of different
selenium compounds are of special interest because it has
been associated with carcinogenicity [2], toxicity [5],
modification of metal toxicity [6] and with prevention of
cancer [7]. In the same field of research, the results of
many studies [8-11] have related Se deficient bioavailabil-
ity and intake to the human cancer mortality.
Organoselenium compounds had substantially greater
bioavailability than that of inorganic selenium [12]. More
importantly, organic selenium is usually found to be less
toxic than inorganic forms of the element [13-16]. New
synthetic selenium compounds may provide a way to
minimize toxicity associated with higher selenium intake.
Recently, several forms of organoselenium have been
studied for their cancer preventive activities. The dietary P-
methoxybenzeneselenol, a synthetic organoselenium
compound was found to inhibit azoxymethane-induced
hepatocarcinogenesis in female F 344 rats without clinical
signs of toxicity [17]. Furthermore, Jibril et al. [18] cited
that El-Bayoumy in 1997 found that two newly synthe-
sized selenium compounds; P-methoxybenzyl selenocy-
anate and 1, 4-phenylenebis (methylene) selenocyanate
prevented both precancerous cell growth and tumor
growth in animals after being treated with a colorectal
cancer-inducing agent with no side effects. Moreover, the
latter authors also cited that Mag et al. (1997) confirmed
antihypertensive properties of some patented phenylami-
noalkyl selenides.
These compounds lowered the blood pressure and
increased blood velocity without increasing heart rate in
experimental animals. More recently, Jibril and his group
[18-20] have succeeded in preparing and characterizing a
new class of organotransition metal S-and Se- bonded thi-
ocarboxylate complexes. From a pharmaceutical point of
view it seemed interesting to examine and compare the
cytogenetic effects of cyclopentadienlydicarbonly ironse-
lenoterephthalic acid (CSe) and its sulfur analogue (CS)
[Figure 1] in cultured rat bone marrow cells. The cytoge-
netic endpoints investigated were SCE, mitotic index (MI)
and cell survival. It should be indicated that these two
compounds have been found to have antibacterial and
antifungal activities. In addition, they were proved to be
nonmutagenic in Salmonella Ames test [20]. However, in
the literature, there are no data of chemopreventive effects




and cyclopentadienylicarbonyl ironthioterephthalic acid
were synthesized and characterized previously [20]. Mito-
mycin C (MMC) was purchased from Janssen Chemica
(Geel; Belgium).
Animals
Male and female Sprague-Dawely rats (10–12 week-old)
were obtained from the animal house unit at Yarmouk
University, Irbid – Jordan.
Preparation of bone marrow cells
Bone marrow cells were obtained according to Krishna et
al [21] with slight modifications. Briefly, rats were lightly
etherized to keep the cells in healthy conditions, then
tibia and femora were isolated and washed in sterile
Hanks Balanced Salt Solution (HBSS) followed by 70%
ethanol. The dissected animals were completely etherized
and properly discarded. Soft tissues and the ends of the
bones were cut away and the cells were flushed using a
syringe with HBSS. After centrifugation at 1000 × g for 10
min, cells were resuspended in an appropriate volume of
fetal calf serum (FCS, PAA Laboratory, GmbH; Austria).
Cell cultures
Prior to establishing the cell cultures, the cells were
washed and mixed evenly in fresh medium and counted
in a hemocytometer to calculate the cell viability as
described below.
A standard bone marrow cell culture was employed
through this study. About 2.0 × 106 cells / ml were placed
in a final volume of 10 ml culture medium in 25 Cm2
flasks. The medium consisted of RPMI 1640 buffered with
25 mM HEPES and supplemented with 15% FCS, 100 IU
penicillin and 150 µg/ml streptomycin. Bromodeoxyurid-
ine (ACROS Organics; USA) was added at the initiation
time at a final concentration of 10 µg/ml. The test chemi-
cals, dissolved in dimethyl sulfoxide (DMSO), were indi-
vidually added at zero, 12 or 24 h of the incubation period
(28 h) at 37°C at the following concentrations: 1.0 × 10-
5, 1.0 × 10-6, 1.0 × 10-7 and 1.0 × 10-8 M. These doses were
selected on the basis of solubility of the test chemicals and
the toxicity of the solvent. This protocol gave a total expo-
sure time of 28, 16 or 4 h, respectively. Mitomycin C (5.0
× 10-8  M) and DMSO (maximum volume 1%) were
included as positive and negative controls, respectively.
Four cultures were made for each treatment. The used
DMSO concentration was based on previous experiments
in our laboratory [22] and work by others [23,24].
Cell harvesting
Cells were harvested as reported previously [25].Journal of Carcinogenesis 2004, 3 http://www.carcinogenesis.com/content/3/1/5
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Cyclopentadienyldicarbonyl ironthioterephthalic acid (CS) and Cyclopentadienyldicarbonyl ironselenoterephthalic acid (CSe) Figure 1
Cyclopentadienyldicarbonyl ironthioterephthalic acid (CS) and Cyclopentadienyldicarbonyl ironselenoterephthalic acid (CSe).
Cyclopentadienyldicarbonyl ironthioterephthalic acid (CS).
Cyclopentadienyldicarbonyl ironselenoterephthalic acid (CSe).
Figure-1.Journal of Carcinogenesis 2004, 3 http://www.carcinogenesis.com/content/3/1/5
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Cell survival
The harvested cells in each culture flask were mixed evenly
as before and the cell viability was determined by the
Trypan blue exclusion technique. The results were
expressed as percentage (Table 1).
SCE frequencies
For every treatment, chromosomes were prepared, stained
and analyzed for SCE as reported before [25]. The number
of SCE/Cell was determined in 20–30 well differentiated
second metaphase cells.
Mitotic index
In the same preparation used for SCE determination, the
MI was calculated for each treatment by screening of 2000
cells from each culture and finding the proportion of
mitotic nuclei.
Results
Cell survival in the CSe- and CS-treated cultures progres-
sively decreased with increasing concentration of both
chemicals, at the three exposure times (Table 1). Statistical
analysis using ANOVA (P < 0.05) and Dunkan's multiple
range test revealed no significant differences between
means of cell survival and those of the negative control.
The general trend was that, with the exception of the 10-8
M treatment, CSe had slightly greater, but still not signifi-
cant, effects on cell survival (Table 1).
Comparison of the CSe and its sulfur analogue shows an
overall phenomenon that is CS delayed cell division to
greater extent than its selenium counterpart. However, the
differences in the MI values were not statistically signifi-
cant (Figures 2, 3). Interestingly, treatment of cultures
with either of the test chemical for 16 h resulted in lower,
but not significant, MI than those calculated in the shorter
(4 h) and the longer (28 h) exposure times.
Unfortunately, the incubation period was not long
enough for the cells to undergo three division cycles.
Therefore, we have not encountered adequate number of
cells that had divided three or more times (M3+) in cul-
ture to allow calculation of the replication index without
bias.
In respect to SCE, The analysis of the data showed that the
SCE frequencies were normally distributed. Thus, there
was no need for either square rootor log transformations
of the original data. Furthermore, the inter-culture varia-
tions within each treatment were not significant. Both
chemicals under study applied for 4 h failed to produce
significant differences over the negative control. But, at
every concentration used, the longer was the period dur-
ing which cells were incubated in the presence of either CS
or CSe, the higher were the SCE levels. About 2-fold
increases were seen, in case of CS, when the longest and
shortest exposure durations were compared (Figure 4).
Only the highest dose of CSe (10-5 M) for 16 or 28 h
nearly doubled the SCE values recorded in the negative
control (10.5 SCE / Cell versus 6.00 to 6.75 SCE/Cell),
respectively. Finally, with exception of the 10-8 M treat-
ment), CSe caused higher rates of SCE (Figures 4, 5).
Discussion
Reinforced by the recent discoveries on biochemical and
pharmacological properties of some organoselenium
compounds we have carried out the present research. To
our knowledge, no work has been published on the
Table 1: The cell survival (%), in cultured rat bone marrow cells treated with either CS or CSe for 4, 16 and 28 hours.
Concentration Cell Survival (%)
(Molar) 4 hr. 16 hr. 28 hr.
Treatment mean ± S.D. mean ± S.D. mean ± S.D.
MMCa 5.0 × 10-8 81.73 ± 4.58 79.17 ± 2.49 70.24 ± 3.51
1.0 × 10-5 92.84 ± 1.95 92.84 ± 2.06 87.49 ± 5.12
1.0 × 10-6 94.34 ± 1.95 92.22 ± 2.1 88.44 ± 2.2
1.0 × 10-7 96.33 ± 3.09 92.97 ± 1.74 91.75 ± 3.16
CS 1.0 × 10-8 98.19 ± 1.65 96.86 ± 0.35 94.86 ± 1.51
1.0 × 10-5 91.88 ± 3.38 88.6 ± 3.33 85.34 ± 3.87
1.0 × 10-6 93.08 ± 3.09 90.75 ± 2.05 87.19 ± 1.74
1.0 × 10-7 98.01 ± 0.80 92.27 ± 2.78 90.97 ± 2.85
Cse 1.0 × 10-8 98.99 ± 1.10 96.41 ± 1.54 95.72 ± 0.38
DMSOb 10 µl 98.09 ± 1.29 94.76 ± 1.98 96.12 ± 1.47
a positive control. b negative control.Journal of Carcinogenesis 2004, 3 http://www.carcinogenesis.com/content/3/1/5
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biological activities of the two cyclopentadienydicarbonyl
iron derivatives used in this study except one [20].
The culture of bone marrow cells is widely accepted as an
in vitro system having an inherently dividing cell popula-
tion without the need for mitogenic induction. It is also
known that the arrangement of cells in the bone marrow
is so disorderly and the cells intermingle with one another
[26]. However, it can be assumed that most of the cells
examined were the lymphoid and the myeloid progenitor
cells which are characterized by their rounded or oval
shapes.
As expected, the positive control (MMC, 5.0 × 10-8 M)
induced 20.25 and 22.75 SCE/Cell when included in the
culture medium for 4 and 28 h, respectively. These values
are consistent with those reported previously [25] where
under similar experimental conditions 18.4 to 26.7 SCE
were observed. This confirms the reproducibility of the
experimental protocol.
Mitotic indices (%) in cultured rat bone marrow cells exposed to different concentrations of CS for three different exposure  times, 4 h, 16 h and 28 h Figure 2
Mitotic indices (%) in cultured rat bone marrow cells exposed to different concentrations of CS for three different exposure 
times, 4 h, 16 h and 28 h.Journal of Carcinogenesis 2004, 3 http://www.carcinogenesis.com/content/3/1/5
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Our data reflect to certain extent the higher reactivity of
organoselenium compounds over their sulfur counter-
parts reported by Odom [1]. Generally speaking, CSe had
slightly greater effect on cell survival (Table 1) and with
the exception of the 10-8 M treatment, it caused more SCE
counts (Figures 4, 5) than its sulfur analogue (CS). In con-
trast, CS seems to have greater abilities to stop cell divi-
sion as indicated by MI (Figures 2, 3). However, not all
these differences were statistically significant. These find-
ings are also in agreement with the results reported in lit-
erature [20] that selenium-containing derivatives were
generally more potent as antimicrobial agents than their
sulfur-containing ones.
The results presented here indicated an inverse relation-
ship between reductions in mitotic activity, and cell via-
bility on one hand and the elevation of SCE rates on the
other. Such relations were reported in Chinese hamster
ovary cells [27], human lymphocytes [22] and rat bone
marrow cells [25].
One major conclusion from the present work is that both
CSe and CS are either not mutagens or weakly mutagens.
According to the GENE-TOX report [28] and the guide-
lines of UKEMS [29], an agent is judged as positive SCE-
inducer when eitherit causes an SCE frequency at least 2-
fold over the baseline level or demonstrates a 3-point
Mitotic indices (%) in cultured rat bone marrow cells exposed to different concentrations of CSe for three different exposure  times, 4 h, 16 h and 28 h Figure 3
Mitotic indices (%) in cultured rat bone marrow cells exposed to different concentrations of CSe for three different exposure 
times, 4 h, 16 h and 28 h.Journal of Carcinogenesis 2004, 3 http://www.carcinogenesis.com/content/3/1/5
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dose-response curve showing a progressive increase over
baseline SCE frequency.
The two compounds under investigation were shown to
be non-mutagenic in Salmonella typhimurium [20]. In view
of this, CSe looks safer than already tested organosele-
nium compounds [22,30] as well asselenopuridine and
selenocystine [15] which had obvious cytogenetic effects
oncultured human lymphocytes.
It has been reported [22] that in vitro exposure of human
lymphocytes to a dimer of Pmethoxybenzeneselenol and
benzylselenocyanate caused 3-fold increase in sister-chro-
matid exchanges and 2 to 3-fold increase in the incidence
of chromosome aberrations (CA). The two compounds
led to inhibition of cell proliferation. In Salmonella typh-
imurium, the above two compounds were founds to be
base-pair substitution mutagens using TA100 strain [30].
Conclusions
CSe has safer cytogenetic effects than already tested orga-
noselenium compounds. Thus, the outcomes of the
present work are not merely of theoretical interest, they
also have practical significance because by the use of suit-
able substituents in organoselenium and organouslfur
compounds it might be possible to obtain drugs with cer-
tain desired features. Clearly, further studies on the two
compounds and other novel ones, used separately or in
combination in different systems, are warranted.
List of abbreviations
CA: Chromosome aberrations
Frequency of SCE/cell in cultured rat bone marrow cells treated different concentrations of CS for three different exposure  times, 4 h, 16 h and 28 h Figure 4
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GSH-Px: Glutathione peroxidase





UKEMES: United Kngdom Environmental Mutagen
Society
Authors' contributions
The authors contributed equally to this work.
Acknowledgements
The authors would like to thank Mr. Issa Jahamani for his distinguished man-
agement of the animals.
References
1. Odom J: Selenium Biochemistry: chemical and physical studies  Ber-
lin:Springer Verlag; 1983:3-12. 
Frequency of SCE/cell in cultured rat bone marrow cells treated different concentrations of CSe for three different exposure  times, 4 h, 16 h and 28 h Figure 5
Frequency of SCE/cell in cultured rat bone marrow cells treated different concentrations of CSe for three different exposure 
times, 4 h, 16 h and 28 h.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Journal of Carcinogenesis 2004, 3 http://www.carcinogenesis.com/content/3/1/5
Page 9 of 9
(page number not for citation purposes)
2. Spallholz JE: On the nature of selenium toxicity and carcinos-
tatic activity. Free Radic Biol Med 1994, 17:45-64.
3. Stadtman TC: Selenium-dependent enzymes. Annual Review of
Biochemistry 1980, 49:93-110.
4. Klayman DL, Güther WH: Organic selenium compounds:their chemistry
and biology New York: John Wiley and Sons, Inc; 1973:728. 
5. Olson OE: Selenium toxicity in animals with emphasis on
Man. Journal of American Collage of toxicology 1986, 5:45-70.
6. Magos L, Webb M: The interactions of selenium with cadmium
and mercury. Crit Rev Toxicol 1980, 8:1-42.
7. Fishbein L: Prespectives on selenium anticarcinogenicity. Toxi-
cology and Environmental Chemistry 1986, 12:1-30.
8. Shamberger RJ: Medical implications of selenium biochemistry.
Trace Elements in Medicine 1986, 3:105-111.
9. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GO, Yang CS,
Zheng SF, Gail M, Li GY  et al.: Nutrition intervention trials in
Laxian, China: supplementation with specific vitamin/min-
eral combinations, cancer incidence and disease specific
mortality in general population.  J Nat Cancer Inst 1993,
85:1483-1491.
10. Insel W: Perspectives in Nutrition New York: Mosby; 1996:396-570. 
11. Vadagama JV, Wu Y, Shen D, Hisa S, Block J: Effect of selenium in
combination with adriamycin or taxol on several cancer
cells. Anticancer Research 2000, 20(3A):1391-1414.
12. Cantor A, Scot M, Noguch T: Biological availability of selenium
in feedstuffs and selenium compounds for prevention of exu-
dative diathesis in chicks. Journal of Nutrition 1976, 105:96-105.
13. Arenholt-Bendsleve D, Abdulla M, Jepsrn A, Pedeson E: Effect of
organic and inorganic selenium on human keratinocytes.
Trace Elements in Medicine 1988, 5:29-34.
14. Khalil AM: The induction of chromosome aberrations in
human purified peripheral blood lymphocytes following in
vitro exposure to selenium. Mutation Research 1989, 224:503-506.
15. Khalil AM: Genotoxicity of two pharmacologically important
selenium compounds (selenocystine and selenopuridine) in
cultured human blood lymphocytes. Toxicology and Environmental
Chemistry 1994, 41:147-154.
16. Saito Y, Fiji T, Honda M, Maeda A, Seo H, Chikuma M: Comparison
of cytotocxic properties of selenium compounds on Ehrlich
Ascites Tumor cells and rat red cells. In Proceedings of the seventh
International Symposium: Selenium in Biology and Medicine: Venenzia .
October 1–5, 2000
17. Tanaka T, Reddy BS, El-Bayoumy K: Inhibition by dietary orga-
noselenium, Pmethoxybenzeneselenol of hepatocarcinogen-
esis induced by azomethane in rats. Japanese Journal of Cancer
Research 1985, 76:462-467.
18. Jibril I, Abd Alhadi E, Hamadah Z: Imide and anhydride briged
organoiron dinuclear homo and hetero dichalcogen carbox-
ylate complexes [CPFe(CO)2  ECO(C6H4)CO]2  NH and
[CPFe(CO)2 ECO(C6H4)CO]2 O [E = S, Se]. Trans Metals in
Chemistry 2000, 25:407-410.
19. Jibril I, Ali AK: Synthesis of organorion thio and seleno-tereph-
thaloyl chloride derivatives and their reactions with organoi-
ron polyhalcogen complexes. Indian Journal of Chemistry 1997, 36
A:987-991.
20. Maslat AO, Jibril I, Abussaud M, Abd Alhadi E, Hamada Z: Synthesis
and biological study of new series of bifunctional organothio-
and seleno-terephthalte derivatives.  Applied Organometalic
Chemistry 2002, 16:44-50.
21. Krishna G, Nath J, Ong N: Preparation of mouse bone marrow
primary cultures for sister chromatid exchanges and chro-
mosomal aberration studies.  Journal of Tissue Culture Methods
1985, 9:193-198.
22. Khalil AM, Maslat AO: Chromosome aberrations, sister-chro-
matid exchanges and cell-cycle kinetics in human peripheral
blood lymphocytes exposed to organoselenium in vitro.
Mutation Research 1990, 232:227-232.
23. Abe S, Sasaki M: Chromosome aberrations and sister chroma-
tid exchanges in Chinese hamster cells exposed to various
chemicals. J Nat Cancer Inst 1977, 58:1635-1641.
24. Ellingham TJ, Christensen EA, Maddock MB: In vitro induction of
sister chromatid exchanges and chromosomal aberrations in
peripheral lymphocytes of the Oyster toadfish and American
eel. Environmental Mutagenesis 1986, 8:555-569.
25. Khalil AM, Dadara AA: The genotoxic and cytotoxic activities of
inorganic flouride in cultured rat bone marrow cells. Archives
of Environmental Contamination and Toxicology 1994, 26:60-63.
26. Till JE, McCulloch EA: Hemopoietic stem cell differentiation.
Biochim Biophys Acta 1980, 605:431-459.
27. Morris SM, Heflich RH: A comparison of toxic and SCE-induc-
ing effects of inhibitors of ADP-ribosyl transferase in Chinese
hamster ovary cells. Mutation Research 1984, 126:63-71.
28. Latt SA, Allen J, Bloom SE, Carrano A, Flake E, Kram D, Schneider ,
S c h r e c k  R ,  T i c e  R ,  W h i t f i e l d  B ,  W o l l f  S :  Sister-chromatid
exchage: A report of the GENE-TOX Program.  Mutation
Research 1981, 87:17-62.
29. UKEMS: Report of the UKEMS Subcommittee of Guidelines
for Mutagenicity Testing. Part I. Basic Test Battery; Minimal
Criteria, Professional Standards, Interpretation, Selection of
Supplementary Assays.  United Kingdom Environmental Mutagen
Society, Swansea; 1983:41-46. 
30. Maslat AO, Khalil AM: Mutagenic effects of two suspected orga-
noselenium compounds in Salmonella typhimrium. Toxicology
and Environmental Chemistry 1991, 33:23-29.